An Oral Agent for the Treatment of Diabetic Retinopathy
Retina Synthesis - A podcast by Retina Synthesis
Categories:
In our latest update, We discuss the use of APX3330 a novel oral agent for the treatment of diabetic retinopathy with Dr. David Boyer, Retina Vitreous Associates, Adjunct Professor USC Roski Eye Institute.
